Filing Summary
Business Context and Reporting Period
ORIC Pharmaceuticals, Inc. filed a Form 8-K dated January 11, 2021 under Items 2.02 and 7.01. The filing reports a corporate update, expected 2021 milestones, and participation in the J.P. Morgan Healthcare Conference. Exhibits include a January 11, 2021 press release and a January 2021 corporate presentation.
Financial and Operating Metrics
The filing text does not provide clear values for revenue, profit or loss, cash flow, margins, debt, liquidity, cash balance, or other financial metrics. Item 2.02 incorporates the Regulation FD disclosure but does not itself include financial results.
Material Changes Versus Prior Period
The filing text does not provide sufficient information to identify material changes versus a prior comparable period.
Guidance, Outlook, Risks, and Unusual Items
The company announced expected milestones for 2021, but the specific milestones and any related guidance are not included in the supplied filing text. The filing does not provide detailed risk factors, contingencies, or unusual financial items. The disclosures were furnished under Regulation FD and are generally not deemed filed for purposes of Section 18 of the Exchange Act.
Investor Verification Items
- Review Exhibit 99.1 for the detailed corporate update and 2021 milestones.
- Review Exhibit 99.2 for the company’s current corporate presentation and development-program information.
- Verify the company’s cash position, operating runway, financing needs, and clinical-development costs in the relevant periodic filing.
- Confirm whether the announced milestones were subsequently achieved and whether timelines or expectations changed.